Preliminary Results from the Respond Trial: Investigator-Driven Study in Portugal to Evaluate Real-Life Safety and Efficacy of Iluvien in Patients with Chronic Dme.
AuthID
P-00M-HH0
P-00M-HH0
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service